GLP-1 and Mindful Portion Control: A Winning Combination for Sustainable Weight Loss
Obesity treatment has undergone a significant shift with the introduction of glucagon-like peptide-1 receptor agonists (GLP-1s) and combination medications, which are revolutionizing the way we approach weight loss. However, despite their effectiveness, real-world challenges and limited clinician and public knowledge on GLP-1 therapy remain major hurdles to their optimal utilization.
Mindful Eating: A Key to Unlocking GLP-1's Full Potential
Studies have consistently demonstrated that mindful eating can have a profound impact on our relationship with food. By incorporating mindful eating practices into our daily routine, we can reduce binge eating episodes, improve portion control, and enhance overall satisfaction with meals. When combined with GLP-1 therapy, these practices become even more effective, as the medication quiets the overwhelming hunger signals that often derail mindful eating attempts.
The Importance of Nutrition Guide While on GLP-1 Medications
- GLP-1 receptor agonists, such as Zepbound (retatrutide), semaglutide (Ozempic, Wegovy), and liraglutide (Saxenda), work by regulating blood sugar levels, promoting weight loss, and reducing appetite.
- Combining these medications with a mindful, balanced diet is crucial to enhance their effectiveness and minimize potential side effects such as nausea, vomiting, and diarrhea.
- A well-planned diet is essential to support weight loss efforts while taking GLP-1 medications. This includes eating smaller, frequent meals, and avoiding high-calorie foods and drinks.
